Research Topics
Species | I CassSummaryAffiliation: Cedars-Sinai Medical Center Country: USA Publications
| Collaborators
|
Detail Information
Publications
Improved survival in women with BRCA-associated ovarian carcinomaIlana Cass
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars Sinai Medical Center and University of California Los Angeles School of Medicine, Los Angeles, California 90048, USAA
Cancer 97:2187-95. 2003..The objective of this study was to determine the clinical characteristics, treatment response, and frequency of p53 overexpression in Ashkenazi Jewish women with hereditary ovarian carcinoma...- Effect of obesity on survival in epithelial ovarian cancerJames C Pavelka
Cedars-Sinai Medical Center, Women's Cancer Research Institute at the Samuel Oschin Comprehensive Cancer Institute, Los Angeles, California, USA
Cancer 107:1520-4. 2006..These findings suggest an effect of excess body weight on tumor biology, and studies are under way to elucidate the molecular and hormonal mechanisms underlying these clinical observations... - Tertiary cytoreductive surgery in recurrent ovarian cancer: selection criteria and survival outcomeAmer K Karam
Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Cedars Sinai Medical Center, 8700 Beverly Blvd, Los Angeles, CA 90048, USA
Gynecol Oncol 104:377-80. 2007..We sought to evaluate the impact of TCS on survival and to determine predictors of optimal tertiary resection... 
Lessons learned in physician reentryIlana Cass
Department Obstetrics and Gynecology, Cedars Sinai Medical Center, Los Angeles, California 90048, USA
Obstet Gynecol 120:360-4. 2012..We no longer will accept a case log with cases drawn from other sites. We also will incorporate an assessment of each candidate's surgical skill using surgical simulation...- Does risk-reducing bilateral salpingo-oophorectomy leave behind residual tube?Ilana Cass
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
Gynecol Oncol 117:27-31. 2010..Risk-reducing bilateral salpingo-oophorectomy (RRSO) is an effective option for women with BRCA mutations however there is limited information as to how much tubal epithelium remains after RRSO... - Allelotype of papillary serous peritoneal carcinomasI Cass
Cedars Sinai Medical Center, Los Angeles, California, 90048, USA
Gynecol Oncol 82:69-76. 2001..The purpose of this study was to determine the incidence of allelic loss and the frequency of p53 mutation by p53 overexpression in PSPC compared to PSOC... - BRCA-mutation-associated fallopian tube carcinoma: a distinct clinical phenotype?Ilana Cass
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California Los Angeles, Cedars Sinai Medical Centers, CA 90048, USA
Obstet Gynecol 106:1327-34. 2005..To compare clinical and histologic features between fallopian tube cancers in women with germline BRCA mutations and sporadic cases... - BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based studyR L Baldwin
Division of Gynecologic Oncology, The Burns and Allen Research Institute Cedars Sinai Medical Center, Los Angeles, California 90048 USA
Cancer Res 60:5329-33. 2000.... - Pattern of lymph node metastases in clinically unilateral stage I invasive epithelial ovarian carcinomasI Cass
Cedars-Sinai Medical Center, Los Angeles, California 90048, USA
Gynecol Oncol 80:56-61. 2001..Ipsilateral sampling may result in the understaging of patients. Bilateral pelvic and paraaortic LN sampling is recommended to accurately stage ovarian carcinoma... - The prognostic significance of thrombocytosis in epithelial ovarian carcinomaAndrew J Li
Department of Obstetrics and Gynecology, Cedars Sinai Medical Center, Geffen School of Medicine at UCLA, Los Angeles, CA 90048, USA
Gynecol Oncol 92:211-4. 2004..Thrombocytosis (platelet counts >400 x 10(9)/l) has been identified as a poor prognostic factor in many cancers. Platelet-secreted factors may contribute to metastasis, invasion, and primary tumor growth... - Characterization of CSOC 882, a novel immortalized ovarian cancer cell line expressing EGFR, HER2, and activated AKTDaniel R Scoles
Women s Cancer Research Institute at Samuel Oschin Comprehensive Cancer Institute and Division of Gynecologic Oncology, CSMC Burns and Allen Research Institute, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
Gynecol Oncol 104:120-8. 2007..We describe a new ovarian cancer cell line that arose from primary culture of a stage IC, grade III ovarian carcinoma, designated CSOC 882... - Coexisting ovarian malignancy in young women with endometrial cancerChristine Walsh
Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, UCLA and Cedars-Sinai Medical Centers, Los Angeles, California 90048, USA
Obstet Gynecol 106:693-9. 2005..Those who desire ovarian preservation should be counseled regarding the high rate of coexisting ovarian malignancy... - Hormone receptor expression in uterine sarcomas: prognostic and therapeutic rolesY J Ioffe
Department of Obstetrics and Gynecology, Cedars Sinai Medical Center, Los Angeles, CA, USA
Gynecol Oncol 115:466-71. 2009..Conducting immunohistochemical staining to ascertain ER status may aid with prognostication in this disease. Hormone therapy should be considered in patients with primary and recurrent ER-positive uterine sarcomas... - The prognostic significance of thrombocytosis in uterine papillary serous carcinomasDimitry L Lerner
Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Cedars Sinai Medical Center, 8700 Beverly Blvd, Suite 160W, Los Angeles, CA 90048, USA
Gynecol Oncol 104:91-4. 2007..In light of the similarities between uterine papillary serous carcinomas (UPSC) and EOC, we sought to determine the incidence of thrombocytosis in UPSC and examine associations with clinico-pathologic features and survival... - Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancerAllison E Axtell
University of California Los Angeles UCLA Medical Center, Los Angeles, CA, USA
J Clin Oncol 25:384-9. 2007..Reciprocally cross validate the predictors identified with those from two previously published cohorts from institutions B and C... - Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositionsJohnathan M Lancaster
H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA
Gynecol Oncol 107:159-62. 2007..This commentary provides guidance on identification of patients who may benefit from hereditary cancer risk assessment for Hereditary Breast/Ovarian Cancer and the Lynch/Hereditary Non-Polyposis Colorectal Cancer syndrome... - Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancerAntonio Santillan
The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, 600 N Wolfe Street, Phipps 281, Baltimore, MD 21287 1281, USA
Gynecol Oncol 104:686-90. 2007..To evaluate the feasibility and associated survival outcome of secondary cytoreductive surgery in patients with isolated lymph node recurrence of epithelial ovarian cancer...